SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vpelt who wrote (924)2/14/2000 4:03:00 PM
From: margie   of 942
 
Some articles of interest about the Pfizer takeover and about Agouron in the agph thread:

"Agouron CEO Johnson Quits"
February 11, 2000
<<SAN DIEGO -- Agouron Pharmaceuticals said yesterday that longtime chief executive Peter Johnson has left the company and is planning to retire after completing a special project for Warner-Lambert.>

and...
From the Financial Times, 2/8/2000
"Warner forced to swallow sharp medicine"
ft.com

<Pfizer was on Monday trying to make reassuring noises about its planned "integration" with Warner-Lambert, saying its policy would be that of "best in class" not "scorched earth".
But there was little disguising who would be running the show after the industry's most acrimonious ever takeover battle.>

"Clearly, this is a takeover financially, not a merger of equals," said Henry McKinnell, who as William Steere's anointed successor at Pfizer will eventually lead the combined company."
....
Message 12867798
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext